Table of Content

1 Report Overview
1.1 Branded Generics Definition
1.2 Market by Type
1.2.1 Global Branded Generics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Topical
1.2.5 Other
1.3 Market Segment by Application
1.3.1 Global Branded Generics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Diabetes
1.3.5 Neurology
1.3.6 Gastrointestinal Diseases
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Branded Generics Sales
2.1 Global Branded Generics Revenue Estimates and Forecasts 2018-2034
2.2 Global Branded Generics Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Branded Generics Revenue by Region
2.3.1 Global Branded Generics Revenue by Region (2018-2024)
2.3.2 Global Branded Generics Revenue by Region (2024-2034)
2.4 Global Branded Generics Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Branded Generics Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Branded Generics Sales Quantity by Region
2.6.1 Global Branded Generics Sales Quantity by Region (2018-2024)
2.6.2 Global Branded Generics Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Branded Generics Sales Quantity by Manufacturers
3.1.1 Global Branded Generics Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Branded Generics Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Branded Generics Sales in 2022
3.2 Global Branded Generics Revenue by Manufacturers
3.2.1 Global Branded Generics Revenue by Manufacturers (2018-2024)
3.2.2 Global Branded Generics Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Branded Generics Revenue in 2022
3.3 Global Branded Generics Sales Price by Manufacturers
3.4 Global Key Players of Branded Generics, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Branded Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Branded Generics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Branded Generics, Product Offered and Application
3.8 Global Key Manufacturers of Branded Generics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Branded Generics Sales Quantity by Type
4.1.1 Global Branded Generics Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Branded Generics Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Branded Generics Sales Quantity Market Share by Type (2018-2034)
4.2 Global Branded Generics Revenue by Type
4.2.1 Global Branded Generics Historical Revenue by Type (2018-2024)
4.2.2 Global Branded Generics Forecasted Revenue by Type (2024-2034)
4.2.3 Global Branded Generics Revenue Market Share by Type (2018-2034)
4.3 Global Branded Generics Price by Type
4.3.1 Global Branded Generics Price by Type (2018-2024)
4.3.2 Global Branded Generics Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Branded Generics Sales Quantity by Application
5.1.1 Global Branded Generics Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Branded Generics Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Branded Generics Sales Quantity Market Share by Application (2018-2034)
5.2 Global Branded Generics Revenue by Application
5.2.1 Global Branded Generics Historical Revenue by Application (2018-2024)
5.2.2 Global Branded Generics Forecasted Revenue by Application (2024-2034)
5.2.3 Global Branded Generics Revenue Market Share by Application (2018-2034)
5.3 Global Branded Generics Price by Application
5.3.1 Global Branded Generics Price by Application (2018-2024)
5.3.2 Global Branded Generics Price Forecast by Application (2024-2034)
6 North America
6.1 North America Branded Generics Sales by Company
6.1.1 North America Branded Generics Revenue by Company (2018-2024)
6.1.2 North America Branded Generics Sales Quantity by Company (2018-2024)
6.2 North America Branded Generics Market Size by Type
6.2.1 North America Branded Generics Sales Quantity by Type (2018-2034)
6.2.2 North America Branded Generics Revenue by Type (2018-2034)
6.3 North America Branded Generics Market Size by Application
6.3.1 North America Branded Generics Sales Quantity by Application (2018-2034)
6.3.2 North America Branded Generics Revenue by Application (2018-2034)
6.4 North America Branded Generics Market Size by Country
6.4.1 North America Branded Generics Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Branded Generics Revenue by Country (2018-2034)
6.4.3 North America Branded Generics Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Branded Generics Sales by Company
7.1.1 Europe Branded Generics Sales Quantity by Company (2018-2024)
7.1.2 Europe Branded Generics Revenue by Company (2018-2024)
7.2 Europe Branded Generics Market Size by Type
7.2.1 Europe Branded Generics Sales Quantity by Type (2018-2034)
7.2.2 Europe Branded Generics Revenue by Type (2018-2034)
7.3 Europe Branded Generics Market Size by Application
7.3.1 Europe Branded Generics Sales Quantity by Application (2018-2034)
7.3.2 Europe Branded Generics Revenue by Application (2018-2034)
7.4 Europe Branded Generics Market Size by Country
7.4.1 Europe Branded Generics Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Branded Generics Revenue by Country (2018-2034)
7.4.3 Europe Branded Generics Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Branded Generics Sales by Company
8.1.1 China Branded Generics Sales Quantity by Company (2018-2024)
8.1.2 China Branded Generics Revenue by Company (2018-2024)
8.2 China Branded Generics Market Size by Type
8.2.1 China Branded Generics Sales Quantity by Type (2018-2034)
8.2.2 China Branded Generics Revenue by Type (2018-2034)
8.3 China Branded Generics Market Size by Application
8.3.1 China Branded Generics Sales Quantity by Application (2018-2034)
8.3.2 China Branded Generics Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Branded Generics Sales by Company
9.1.1 APAC Branded Generics Sales Quantity by Company (2018-2024)
9.1.2 APAC Branded Generics Revenue by Company (2018-2024)
9.2 APAC Branded Generics Market Size by Type
9.2.1 APAC Branded Generics Sales Quantity by Type (2018-2034)
9.2.2 APAC Branded Generics Revenue by Type (2018-2034)
9.3 APAC Branded Generics Market Size by Application
9.3.1 APAC Branded Generics Sales Quantity by Application (2018-2034)
9.3.2 APAC Branded Generics Revenue by Application (2018-2034)
9.4 APAC Branded Generics Market Size by Region
9.4.1 APAC Branded Generics Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Branded Generics Revenue by Region (2018-2034)
9.4.3 APAC Branded Generics Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Branded Generics Sales by Company
10.1.1 Middle East, Africa and Latin America Branded Generics Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Branded Generics Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Branded Generics Market Size by Type
10.2.1 Middle East, Africa and Latin America Branded Generics Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Branded Generics Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Branded Generics Market Size by Application
10.3.1 Middle East, Africa and Latin America Branded Generics Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Branded Generics Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Branded Generics Market Size by Country
10.4.1 Middle East, Africa and Latin America Branded Generics Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Branded Generics Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Branded Generics Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Mylan NV
11.1.1 Mylan NV Company Information
11.1.2 Mylan NV Overview
11.1.3 Mylan NV Branded Generics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Mylan NV Branded Generics Products and Services
11.1.5 Mylan NV Branded Generics SWOT Analysis
11.1.6 Mylan NV Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Branded Generics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Novartis AG Branded Generics Products and Services
11.2.5 Novartis AG Branded Generics SWOT Analysis
11.2.6 Novartis AG Recent Developments
11.3 Eva Pharmaceutical Industries
11.3.1 Eva Pharmaceutical Industries Company Information
11.3.2 Eva Pharmaceutical Industries Overview
11.3.3 Eva Pharmaceutical Industries Branded Generics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Eva Pharmaceutical Industries Branded Generics Products and Services
11.3.5 Eva Pharmaceutical Industries Branded Generics SWOT Analysis
11.3.6 Eva Pharmaceutical Industries Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Branded Generics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Pfizer Branded Generics Products and Services
11.4.5 Pfizer Branded Generics SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Company Information
11.5.2 Sun Pharmaceutical Industries Overview
11.5.3 Sun Pharmaceutical Industries Branded Generics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Sun Pharmaceutical Industries Branded Generics Products and Services
11.5.5 Sun Pharmaceutical Industries Branded Generics SWOT Analysis
11.5.6 Sun Pharmaceutical Industries Recent Developments
11.6 Aspen Pharmacare Holding
11.6.1 Aspen Pharmacare Holding Company Information
11.6.2 Aspen Pharmacare Holding Overview
11.6.3 Aspen Pharmacare Holding Branded Generics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Aspen Pharmacare Holding Branded Generics Products and Services
11.6.5 Aspen Pharmacare Holding Branded Generics SWOT Analysis
11.6.6 Aspen Pharmacare Holding Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Branded Generics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Abbott Laboratories Branded Generics Products and Services
11.7.5 Abbott Laboratories Branded Generics SWOT Analysis
11.7.6 Abbott Laboratories Recent Developments
11.8 Bausch Health
11.8.1 Bausch Health Company Information
11.8.2 Bausch Health Overview
11.8.3 Bausch Health Branded Generics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Bausch Health Branded Generics Products and Services
11.8.5 Bausch Health Branded Generics SWOT Analysis
11.8.6 Bausch Health Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Branded Generics Value Chain Analysis
12.2 Branded Generics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Branded Generics Production Mode & Process
12.4 Branded Generics Sales and Marketing
12.4.1 Branded Generics Sales Channels
12.4.2 Branded Generics Distributors
12.5 Branded Generics Customers
13 Market Dynamics
13.1 Branded Generics Industry Trends
13.2 Branded Generics Market Drivers
13.3 Branded Generics Market Challenges
13.4 Branded Generics Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Branded Generics Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Parenteral
Table 4. Major Manufacturers of Topical
Table 5. Major Manufacturers of Other
Table 6. Global Branded Generics Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Branded Generics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Branded Generics Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Branded Generics Revenue Market Share by Region (2018-2024)
Table 10. Global Branded Generics Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Branded Generics Revenue Market Share by Region (2024-2034)
Table 12. Global Branded Generics Sales Quantity by Region: 2018 VS 2022 VS 2034 (K MT)
Table 13. Global Branded Generics Sales by Region (2018-2024) & (K MT)
Table 14. Global Branded Generics Sales Market Share by Region (2018-2024)
Table 15. Global Branded Generics Sales by Region (2024-2034) & (K MT)
Table 16. Global Branded Generics Sales Market Share by Region (2024-2034)
Table 17. Global Branded Generics Sales Quantity by Manufacturers (2018-2024) & (K MT)
Table 18. Global Branded Generics Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Branded Generics Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Branded Generics Revenue Share by Manufacturers (2018-2024)
Table 21. Global Branded Generics Price by Manufacturers 2018-2024 (USD/MT)
Table 22. Global Key Players of Branded Generics, Industry Ranking, 2021 VS 2022
Table 23. Global Branded Generics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Branded Generics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Branded Generics as of 2022)
Table 25. Global Key Manufacturers of Branded Generics, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Branded Generics, Product Offered and Application
Table 27. Global Key Manufacturers of Branded Generics, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Branded Generics Sales Quantity by Type (2018-2024) & (K MT)
Table 30. Global Branded Generics Sales Quantity by Type (2024-2034) & (K MT)
Table 31. Global Branded Generics Sales Quantity Share by Type (2018-2024)
Table 32. Global Branded Generics Sales Quantity Share by Type (2024-2034)
Table 33. Global Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Branded Generics Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Branded Generics Revenue Share by Type (2018-2024)
Table 36. Global Branded Generics Revenue Share by Type (2024-2034)
Table 37. Branded Generics Price by Type (2018-2024) & (USD/MT)
Table 38. Global Branded Generics Price Forecast by Type (2024-2034) & (USD/MT)
Table 39. Global Branded Generics Sales Quantity by Application (2018-2024) & (K MT)
Table 40. Global Branded Generics Sales Quantity by Application (2024-2034) & (K MT)
Table 41. Global Branded Generics Sales Quantity Share by Application (2018-2024)
Table 42. Global Branded Generics Sales Quantity Share by Application (2024-2034)
Table 43. Global Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Branded Generics Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Branded Generics Revenue Share by Application (2018-2024)
Table 46. Global Branded Generics Revenue Share by Application (2024-2034)
Table 47. Branded Generics Price by Application (2018-2024) & (USD/MT)
Table 48. Global Branded Generics Price Forecast by Application (2024-2034) & (USD/MT)
Table 49. North America Branded Generics Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Branded Generics Sales Quantity by Company (2018-2024) & (K MT)
Table 51. North America Branded Generics Sales Quantity by Type (2018-2024) & (K MT)
Table 52. North America Branded Generics Sales Quantity by Type (2024-2034) & (K MT)
Table 53. North America Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Branded Generics Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Branded Generics Sales Quantity by Application (2018-2024) & (K MT)
Table 56. North America Branded Generics Sales Quantity by Application (2024-2034) & (K MT)
Table 57. North America Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Branded Generics Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Branded Generics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Branded Generics Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Branded Generics Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Branded Generics Sales Quantity by Country (2018-2024) & (K MT)
Table 63. North America Branded Generics Sales Quantity by Country (2024-2034) & (K MT)
Table 64. Europe Branded Generics Sales Quantity by Company (2018-2024) & (K MT)
Table 65. Europe Branded Generics Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Branded Generics Sales Quantity by Type (2018-2024) & (K MT)
Table 67. Europe Branded Generics Sales Quantity by Type (2024-2034) & (K MT)
Table 68. Europe Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Branded Generics Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Branded Generics Sales Quantity by Application (2018-2024) & (K MT)
Table 71. Europe Branded Generics Sales Quantity by Application (2024-2034) & (K MT)
Table 72. Europe Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Branded Generics Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Branded Generics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Branded Generics Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Branded Generics Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Branded Generics Sales Quantity by Country (2018-2024) & (K MT)
Table 78. Europe Branded Generics Sales Quantity by Country (2024-2034) & (K MT)
Table 79. China Branded Generics Sales Quantity by Company (2018-2024) & (K MT)
Table 80. China Branded Generics Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Branded Generics Sales Quantity by Type (2018-2024) & (K MT)
Table 82. China Branded Generics Sales Quantity by Type (2024-2034) & (K MT)
Table 83. China Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Branded Generics Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Branded Generics Sales Quantity by Application (2018-2024) & (K MT)
Table 86. China Branded Generics Sales Quantity by Application (2024-2034) & (K MT)
Table 87. China Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Branded Generics Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Branded Generics Sales Quantity by Company (2018-2024) & (K MT)
Table 90. APAC Branded Generics Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Branded Generics Sales Quantity by Type (2018-2024) & (K MT)
Table 92. APAC Branded Generics Sales Quantity by Type (2024-2034) & (K MT)
Table 93. APAC Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Branded Generics Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Branded Generics Sales Quantity by Application (2018-2024) & (K MT)
Table 96. APAC Branded Generics Sales Quantity by Application (2024-2034) & (K MT)
Table 97. APAC Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Branded Generics Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Branded Generics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Branded Generics Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Branded Generics Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Branded Generics Sales Quantity by Region (2018-2024) & (K MT)
Table 103. APAC Branded Generics Sales Quantity by Region (2024-2034) & (K MT)
Table 104. Middle East, Africa and Latin America Branded Generics Sales Quantity by Company (2018-2024) & (K MT)
Table 105. Middle East, Africa and Latin America Branded Generics Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Branded Generics Sales Quantity by Type (2018-2024) & (K MT)
Table 107. Middle East, Africa and Latin America Branded Generics Sales Quantity by Type (2024-2034) & (K MT)
Table 108. Middle East, Africa and Latin America Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Branded Generics Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Branded Generics Sales Quantity by Application (2018-2024) & (K MT)
Table 111. Middle East, Africa and Latin America Branded Generics Sales Quantity by Application (2024-2034) & (K MT)
Table 112. Middle East, Africa and Latin America Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Branded Generics Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Branded Generics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Branded Generics Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Branded Generics Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Branded Generics Sales Quantity by Country (2018-2024) & (K MT)
Table 118. Middle East, Africa and Latin America Branded Generics Sales Quantity by Country (2024-2034) & (K MT)
Table 119. Mylan NV Company Information
Table 120. Mylan NV Description and Overview
Table 121. Mylan NV Branded Generics Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 122. Mylan NV Branded Generics Product and Services
Table 123. Mylan NV Branded Generics SWOT Analysis
Table 124. Mylan NV Recent Developments
Table 125. Novartis AG Company Information
Table 126. Novartis AG Description and Overview
Table 127. Novartis AG Branded Generics Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 128. Novartis AG Branded Generics Product and Services
Table 129. Novartis AG Branded Generics SWOT Analysis
Table 130. Novartis AG Recent Developments
Table 131. Eva Pharmaceutical Industries Company Information
Table 132. Eva Pharmaceutical Industries Description and Overview
Table 133. Eva Pharmaceutical Industries Branded Generics Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 134. Eva Pharmaceutical Industries Branded Generics Product and Services
Table 135. Eva Pharmaceutical Industries Branded Generics SWOT Analysis
Table 136. Eva Pharmaceutical Industries Recent Developments
Table 137. Pfizer Company Information
Table 138. Pfizer Description and Overview
Table 139. Pfizer Branded Generics Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 140. Pfizer Branded Generics Product and Services
Table 141. Pfizer Branded Generics SWOT Analysis
Table 142. Pfizer Recent Developments
Table 143. Sun Pharmaceutical Industries Company Information
Table 144. Sun Pharmaceutical Industries Description and Overview
Table 145. Sun Pharmaceutical Industries Branded Generics Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 146. Sun Pharmaceutical Industries Branded Generics Product and Services
Table 147. Sun Pharmaceutical Industries Branded Generics SWOT Analysis
Table 148. Sun Pharmaceutical Industries Recent Developments
Table 149. Aspen Pharmacare Holding Company Information
Table 150. Aspen Pharmacare Holding Description and Overview
Table 151. Aspen Pharmacare Holding Branded Generics Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 152. Aspen Pharmacare Holding Branded Generics Product and Services
Table 153. Aspen Pharmacare Holding Branded Generics SWOT Analysis
Table 154. Aspen Pharmacare Holding Recent Developments
Table 155. Abbott Laboratories Company Information
Table 156. Abbott Laboratories Description and Overview
Table 157. Abbott Laboratories Branded Generics Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 158. Abbott Laboratories Branded Generics Product and Services
Table 159. Abbott Laboratories Branded Generics SWOT Analysis
Table 160. Abbott Laboratories Recent Developments
Table 161. Bausch Health Company Information
Table 162. Bausch Health Description and Overview
Table 163. Bausch Health Branded Generics Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 164. Bausch Health Branded Generics Product and Services
Table 165. Bausch Health Branded Generics SWOT Analysis
Table 166. Bausch Health Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Branded Generics Distributors List
Table 170. Branded Generics Customers List
Table 171. Branded Generics Market Trends
Table 172. Branded Generics Market Drivers
Table 173. Branded Generics Market Challenges
Table 174. Branded Generics Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Branded Generics Product Picture
Figure 2. Global Branded Generics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Branded Generics Market Share by Type in 2022 & 2034
Figure 4. Oral Product Picture
Figure 5. Parenteral Product Picture
Figure 6. Topical Product Picture
Figure 7. Other Product Picture
Figure 8. Global Branded Generics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Branded Generics Market Share by Application in 2022 & 2034
Figure 10. Oncology
Figure 11. Cardiovascular Diseases
Figure 12. Diabetes
Figure 13. Neurology
Figure 14. Gastrointestinal Diseases
Figure 15. Others
Figure 16. Branded Generics Report Years Considered
Figure 17. Global Branded Generics Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Branded Generics Revenue 2018-2034 (US$ Million)
Figure 19. Global Branded Generics Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 20. Global Branded Generics Sales Quantity 2018-2034 (K MT)
Figure 21. Global Branded Generics Sales Quantity Market Share by Region (2018-2024)
Figure 22. Global Branded Generics Sales Quantity Market Share by Region (2024-2034)
Figure 23. North America Branded Generics Sales Quantity YoY (2018-2034) & (K MT)
Figure 24. North America Branded Generics Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Europe Branded Generics Sales Quantity YoY (2018-2034) & (K MT)
Figure 26. Europe Branded Generics Revenue YoY (2018-2034) & (US$ Million)
Figure 27. China Branded Generics Sales Quantity YoY (2018-2034) & (K MT)
Figure 28. China Branded Generics Revenue YoY (2018-2034) & (US$ Million)
Figure 29. APAC Branded Generics Sales Quantity YoY (2018-2034) & (K MT)
Figure 30. APAC Branded Generics Revenue YoY (2018-2034) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Branded Generics Sales Quantity YoY (2018-2034) & (K MT)
Figure 32. Middle East, Africa and Latin America Branded Generics Revenue YoY (2018-2034) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Branded Generics Sales Quantity in 2022
Figure 34. The Top 10 and Top 5 Players Market Share by Branded Generics Revenue in 2022
Figure 35. Branded Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Branded Generics Sales Quantity Market Share by Type (2018-2034)
Figure 37. Global Branded Generics Revenue Market Share by Type (2018-2034)
Figure 38. Global Branded Generics Sales Quantity Market Share by Application (2018-2034)
Figure 39. Global Branded Generics Revenue Market Share by Application (2018-2034)
Figure 40. North America Branded Generics Revenue Market Share by Company in 2022
Figure 41. North America Branded Generics Sales Quantity Market Share by Company in 2022
Figure 42. North America Branded Generics Sales Quantity Market Share by Type (2018-2034)
Figure 43. North America Branded Generics Revenue Market Share by Type (2018-2034)
Figure 44. North America Branded Generics Sales Quantity Market Share by Application (2018-2034)
Figure 45. North America Branded Generics Revenue Market Share by Application (2018-2034)
Figure 46. North America Branded Generics Revenue Share by Country (2018-2034)
Figure 47. North America Branded Generics Sales Quantity Share by Country (2018-2034)
Figure 48. U.S. Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 49. Canada Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 50. Europe Branded Generics Sales Quantity Market Share by Company in 2022
Figure 51. Europe Branded Generics Revenue Market Share by Company in 2022
Figure 52. Europe Branded Generics Sales Quantity Market Share by Type (2018-2034)
Figure 53. Europe Branded Generics Revenue Market Share by Type (2018-2034)
Figure 54. Europe Branded Generics Sales Quantity Market Share by Application (2018-2034)
Figure 55. Europe Branded Generics Revenue Market Share by Application (2018-2034)
Figure 56. Europe Branded Generics Revenue Share by Country (2018-2034)
Figure 57. Europe Branded Generics Sales Quantity Share by Country (2018-2034)
Figure 58. Germany Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 59. France Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 60. U.K. Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 61. Italy Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 62. Russia Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 63. China Branded Generics Sales Quantity Market Share by Company in 2022
Figure 64. China Branded Generics Revenue Market Share by Company in 2022
Figure 65. China Branded Generics Sales Quantity Market Share by Type (2018-2034)
Figure 66. China Branded Generics Revenue Market Share by Type (2018-2034)
Figure 67. China Branded Generics Sales Quantity Market Share by Application (2018-2034)
Figure 68. China Branded Generics Revenue Market Share by Application (2018-2034)
Figure 69. APAC Branded Generics Sales Quantity Market Share by Company in 2022
Figure 70. APAC Branded Generics Revenue Market Share by Company in 2022
Figure 71. APAC Branded Generics Sales Quantity Market Share by Type (2018-2034)
Figure 72. APAC Branded Generics Revenue Market Share by Type (2018-2034)
Figure 73. APAC Branded Generics Sales Quantity Market Share by Application (2018-2034)
Figure 74. APAC Branded Generics Revenue Market Share by Application (2018-2034)
Figure 75. APAC Branded Generics Revenue Share by Region (2018-2034)
Figure 76. APAC Branded Generics Sales Quantity Share by Region (2018-2034)
Figure 77. Japan Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 78. South Korea Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 79. China Taiwan Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 80. Southeast Asia Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 81. India Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 82. Middle East, Africa and Latin America Branded Generics Sales Quantity Market Share by Company in 2022
Figure 83. Middle East, Africa and Latin America Branded Generics Revenue Market Share by Company in 2022
Figure 84. Middle East, Africa and Latin America Branded Generics Sales Quantity Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Branded Generics Revenue Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Branded Generics Sales Quantity Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Branded Generics Revenue Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Branded Generics Sales Quantity Share by Country (2018-2034)
Figure 89. Middle East, Africa and Latin America Branded Generics Revenue Share by Country (2018-2034)
Figure 90. Brazil Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 91. Mexico Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 92. Turkey Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 93. Israel Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 94. GCC Countries Branded Generics Revenue (2018-2034) & (US$ Million)
Figure 95. Branded Generics Value Chain
Figure 96. Branded Generics Production Process
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed